We are live on ! Find out more
AC

Almitas Capital Portfolio holdings

AUM $417M
1-Year Est. Return 22.81%
This Fund
S&P 500
This Quarter Est. Return
-2.76%
1 Year Est. Return
+22.81%
3 Year Est. Return
+86.09%
5 Year Est. Return
10 Year Est. Return
AUM
$443M
AUM Growth
-$11.6M
Cap. Flow
+$39.4M
Cap. Flow %
8.89%
Top 10 Hldgs %
57.81%
Holding
137
New
31
Increased
31
Reduced
16
Closed
22

Sector Composition

Rank Sector Weight
1 Miscellaneous 65.84%
2 Healthcare 19.22%
3 Financials 5.65%
4 Real Estate 4.84%
5 Consumer Discretionary 2.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBTC icon
1
Fidelity Wise Origin Bitcoin Fund
FBTC
$14.4B
$90.7M 20.5%
1,536,637
BTT icon
2
BlackRock Municipal 2030 Target Term Trust
BTT
$1.44B
$33.7M 7.62%
1,486,013
ASA
3
ASA Gold and Precious Metals
ASA
$1.19B
$32.6M 7.37%
525,666
+143,527
+38% +$9.69M
AMLX icon
4
Amylyx Pharmaceuticals
AMLX
$3.87B
$29.5M 6.67%
2,122,597
DSGN icon
5
Design Therapeutics
DSGN
$946M
$16.3M 3.68%
1,530,335
-100
-0% -$1.01K
NQP
6
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
$12.6M 2.85%
1,057,494
+688,699
+187% +$8.22M
PDX
7
PIMCO Dynamic Income Strategy Fund
PDX
$968M
$11.9M 2.7%
541,492
+390,232
+258% +$7.91M
LYEL icon
8
Lyell Immunopharma
LYEL
$356M
$11.6M 2.62%
577,807
BIO icon
9
Bio-Rad Laboratories Class A
BIO
$10.4B
$8.43M 1.91%
+30,254
New +$8.71M
CNNE icon
10
Cannae Holdings
CNNE
$678M
$8.43M 1.9%
741,318
+329,425
+80% +$4.42M
CRF
11
Cornerstone Total Return Fund
CRF
$1.1B
$7.75M 1.75%
1,115,348
+1,028,931
+1,191% +$7.73M
BMEZ icon
12
BlackRock Health Sciences Trust II
BMEZ
$1.05B
$7.27M 1.64%
506,395
+353,481
+231% +$5.25M
ALXO icon
13
ALX Oncology
ALXO
$277M
$6.36M 1.44%
3,173,834
+636,943
+25% +$1.21M
BRSP
14
BrightSpire Capital
BRSP
$601M
$5.69M 1.29%
1,015,903
-13,561
-1% -$78.5K
DSM
15
BNY Mellon Strategic Municipal Bond Fund
DSM
$288M
$5.57M 1.26%
926,301
CMU
16
DELISTED
MFS High Yield Municipal Trust
CMU
$5.36M 1.21%
1,497,718
PCQ
17
Pimco California Municipal Income Fund
PCQ
$166M
$5.29M 1.2%
617,015
-23,592
-4% -$210K
ELME
18
Elme Communities
ELME
$149M
$5.24M 1.18%
2,607,372
+1,595,162
+158% +$5.26M
MRCC
19
DELISTED
Monroe Capital Corp
MRCC
$5.18M 1.17%
1,277,717
+278,673
+28% +$1.61M
ANTX icon
20
AN2 Therapeutics
ANTX
$211M
$5.06M 1.14%
1,479,129
CXE
21
DELISTED
MFS High Income Municipal Trust
CXE
$4.7M 1.06%
1,266,853
+72,967
+6% +$276K
MEGI
22
NYLIM CBRE Global Infrastructure Megatrends Term Fund
MEGI
$771M
$4.64M 1.05%
316,133
+254,480
+413% +$3.71M
JOF
23
Japan Smaller Capitalization Fund
JOF
$358M
$4.39M 0.99%
402,956
-33,029
-8% -$377K
CCAP icon
24
Crescent Capital BDC
CCAP
$388M
$4.34M 0.98%
356,905
-87,329
-20% -$1.19M
DTF
25
DTF Tax-Free Income 2028 Term Fund
DTF
$81.4M
$4.07M 0.92%
355,089
+4,149
+1% +$47.5K

Similar funds

Almitas Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Almitas Capital held 137 positions worth $443M, down 2.6% from $454M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Almitas Capital deployed $39.4M of net new capital in Q1 2026, opening 31 new positions and adding to 31 existing holdings. Its largest new stake was Bio-Rad Laboratories Class A: 30,254 shares worth $8.43M.

By sector, the portfolio is most concentrated in Miscellaneous at 66% of assets, up from 64% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was FS Specialty Lending Fund, an estimated $6.95M trimmed.

  • Almitas Capital's largest Q1 2026 buy was Bio-Rad Laboratories Class A: 30,254 shares worth $8.43M.
  • Almitas Capital added most to ASA Gold and Precious Metals in Q1 2026, an estimated $9.69M increase.
  • Almitas Capital's biggest Q1 2026 reduction was FS Specialty Lending Fund, cutting an estimated $6.95M.
  • Almitas Capital fully exited Fidelity Ethereum Fund in Q1 2026, selling an estimated $19.2M.
  • Almitas Capital's ten largest holdings make up 58% of its $443M portfolio in Q1 2026.
  • Almitas Capital opened 31 new positions and closed 22 in Q1 2026.
  • Almitas Capital's portfolio value fell 2.6% quarter-over-quarter to $443M.

Based on Almitas Capital's 13F filing for Q1 2026, filed 15 May 2026.